Differential corticosteroid receptor regulation of mesoaccumbens dopamine efflux during the peak and nadir of the circadian rhythm: A molecular equilibrium in the midbrain?

Synapse

Volumn 63, Issue 11, 2009, Pages 982-990

  Tye, Susannah J ^a   Miller, Anthony D ^b   Blaha, Charles D ^b  

^a MAYO CLINIC   (United States)

^b University of Memphis   (United States)

Author keywords

Chronoamperometry; Corticosterone; Glucocorticoid; Mineralocorticoid; Ventral tegmentum

Indexed keywords

ALDOSTERONE; CORTICOSTEROID RECEPTOR; CORTICOSTERONE; DOPAMINE; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; ELECTRODE; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ANIMALS; CIRCADIAN RHYTHM; DOPAMINE; MALE; MESENCEPHALON; NUCLEUS ACCUMBENS; RATS; RATS, LONG-EVANS; RECEPTORS, STEROID;

EID: 70349274486     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20682     Document Type: Article

References (62)

1. Aragona BJ, Cleaveland NA, Stuber GD, Day JJ, Carelli RM, Wightman RM. 2008. Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J Neurosci 28:8821-8831.
2. Atkinson HC, Waddell BJ. 1997. Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: Sexual dimorphism and changes across the estrous cycle. Endocrinology 138:3482-3488.
3. Barrot M, Marinelli M, Abrous DN, Rougé-Pont F, Le Moal M, Piazza PV. 2000. The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci 12:973-979. (Pubitemid 30168775)
4. Blaha CD. 1996. Evaluation of stearate-graphite paste electrodes for chronic measurement of extracellular dopamine concentrations in the mammalian brain. Pharmacol Biochem Behav 55:351-364.
5. Blaha CD, Jung ME. 1991. Electrochemical evaluation of stearate-modified graphite paste electrodes: Selective detection of dopamine is maintained after exposure to brain tissue. J Electroanal Chem 310:317-334.
6. Blaha CD, Phillips AG. 1996. A critical assessment of electrochemical procedures applied to measurement of dopamine and its metabolites during drug-induced and species-typical behaviors. Behav Pharmacol 7:675-708.
7. Blaha CD, Winn P. 1993. Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental nucleus-lesioned rats. J Neurosci 13:1035-1044. (Pubitemid 23067591)
8. Brinks V, van der Mark MH, de Kloet ER, Oitzl MS. 2007. Differential MR/GR activation in mice results in emotional states beneficial or impairing for cognition. Neural Plast 2007:90163. (Pubitemid 46629679)
9. Carrasco GA, Van de Kar LD. 2003. Neuroendocrine pharmacology of stress. Eur J Pharmacol 463:235-272.
10. Castañeda TR, de Prado BM, Prieto D, Mora F. 2004. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: Modulation by light. J Pineal Res 36:177-185. (Pubitemid 38429283)
11. Cho K, Little HJ. 1999. Effects of corticosterone on excitatory amino acid responses in dopamine-sensitive neurons in the ventral tegmental area. Neuroscience 88:837-845. (Pubitemid 28518261)
12. Clark D, Overton PG. 1998. Alterations in excitatory amino acid-mediated regulation of midbrain dopaminergic neurones induced by chronic psychostimulant administration and stress: Relevance to behavioural sensitization and drug addiction. Addiction Biol 3:109-135. (Pubitemid 28190955)
13. de Jong IE, de Kloet ER. 2004. Glucocorticoids and vulnerability to psychostimulant drugs: Toward substrate and mechanism. Ann NY Acad Sci 1018:192-198.
14. de Kloet ER, Reul JM, Sutanto W. 1990. Corticosteroids and the brain. J Steroid Biochem Mol Biol 37:387-394.
15. de Kloet ER, Vreugdenhil E, Oitzl MS, Jöels M. 1998. Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301. (Pubitemid 29117816)
16. Delyani JA. 2000. Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology. Kidney Int 57:1408-1411. (Pubitemid 30207899)
17. Feenstra MG, Botterblom MH, Mastenbroek S. 2000. Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: Effects of novelty and handling and comparison to the nucleus accumbens. Neuroscience 100:741-748. (Pubitemid 30742278)
18. Floresco SB, West AR, Ash B, Moore H, Grace AA. 2003. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6:968-973. (Pubitemid 37064759)
19. Forster GL, Blaha CD. 2000. Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area. Eur J Neurosci 12:3596-3604. (Pubitemid 30796062)
20. Forster GL, Blaha CD. 2003. Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat. Eur J Neurosci 17:751-762.
21. Gómez-Sánchez EP, Fort CM, Gómez-Sánchez CE. 1990a. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol 258:E482-E484.
22. Gómez-Sánchez EP, Venkataraman MT, Thwaites D, Fort C. 1990b. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol 258:E649-E653.
23. Hampp G, Ripperger JA, Houben T, Schmutz I, Blex C, Perreau-Lenz S, Brunk I, Spanagel R, Ahnert-Hilger G, Meijer JH, Albrecht U. 2008. Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol 18:678-683.
24. Hamstra WN, Doray D, Dunn JD. 1984. The effect of urethane on pituitary-adrenal function of female rats. Acta Endocrinol (Copenh) 106:362-367. (Pubitemid 14081701)
25. Handa RJ, Zuloaga DG, McGivern RF. 2007. Prenatal ethanol exposure alters core body temperature and corticosterone rhythms in adult male rats. Alcohol 41:567-575.
26. Heikinheimo O. 1997. Clinical pharmacokinetics of mifepristone. Clin Pharmacokinet 33:7-17.
27. Imperato A, Puglisi-Allegra S, Casolini P, Angelucci L. 1991. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res 538:111-117.
28. Jöels M. 2000. Modulatory actions of steroid hormones and neuropeptides on electrical activity in the brain. Eur J Neurosci 405:207-216. (Pubitemid 30734180)
29. Joëls M, de Kloet ER. 1992a. Control of neuronal excitability by corticosteroid hormones. Trends Neurosci 15:25-30.
30. Joëls M, de Kloet ER. 1992b. Coordinative mineralocorticoid and glucocorticoid receptor-mediated control of responses to serotonin in rat hippocampus. Neuroendocrinology 55:344-350.
31. Jones SR, O'Dell SJ, Marshall JF, Wightman RM. 1996. Functional and anatomical evidence for different dopamine dynamics in the core and shell of the nucleus accumbens in slices of rat brain. Synapse 23:224-231.
32. Kabbaj M, Devine DP, Savage VR, Akil H. 2000. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: Differential expression of stress-related molecules. J Neurosci 20:6983-6988. (Pubitemid 30708025)
33. Karoum F, Chrapusta SJ, Egan MF. 1994. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 63:972-979. (Pubitemid 24983998)
34. Lindley SE, Bengoechea TG, Wong DL, Schatzberg AF. 2002. Mesotelencephalic dopamine neurochemical responses to glucocorticoid administration and adrenalectomy in Fischer 344 and Lewis rats. Brain Res 958:414-422.
35. Mahajan DK, London SN. 1997. Mifepristone (RU486): A review. Fertil Steril 68:967-976.
36. Marinelli M. 2007.Dopaminergic reward pathways and effects of stress. In:al'Absi M, editor. Stress and addiction: Biological and psychological mechanisms. San Diego, CA, USA: Elsevier Ltd. p 41-83.
37. Marinelli M, Piazza PV, Deroche V, Maccari S, Le Moal M, Simon H. 1994. Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine. J Neurosci 14:2724-2731. (Pubitemid 24983668)
38. Marinelli M, Aouizerate B, Barrot M, Le Moal M, Piazza PV. 1998. Dopamine-dependent responses to morphine depend on glucocorticoid receptors. Proc Natl Acad Sci USA 95:7742-7747. (Pubitemid 28293324)
39. Miller AD, Blaha CD. 2005. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat. Eur J Neurosci 21:1837-1846.
40. Miller AD, Forster GL, Yeomans JS, Blaha CD. 2005. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat. Neuroscience 136:531-538.
41. Mittleman G, Blaha CD, Phillips AG. 1992. Pituitary-adrenal and dopaminergic modulation of schedule-induced polydipsia: Behavioral and neurochemical evidence. Behav Neurosci 106:408-420.
42. Monti JM, Monti D. 2007. The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev 11:113-133. (Pubitemid 46330853)
43. Müller MB, Keck ME, Zimmermann S, Holsboer F, Wurst W. 2000. Disruption of feeding behavior in CRH receptor 1-deficient mice is dependent on glucocorticoids. Neuroreport 11:1963-1966. (Pubitemid 30429144)
44. Nirenberg MJ, Chan J, Pohorille A, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. 1997. The dopamine transporter: Comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17:6899-6907. (Pubitemid 27427868)
45. Ondo JG, Kitay JI. 1973. Effects of urethane on pituitary-adrenal function in the rat. Proc Soc Exp Biol Med 143:894-898.
46. Overton PG, Tong ZY, Brain PF, Clark D. 1996. Preferential occupation of mineralocorticoid receptors by corticosterone enhances glutamate-induced burst firing in rat midbrain dopaminergic neurons. Brain Res 737:146-154. (Pubitemid 26366608)
47. Owens MJ, Bartolome J, Schanberg SM, Nemeroff CB. 1990. Corticotropin-releasing factor concentrations exhibit an apparent diurnal rhythm in hypothalamic and extrahypothalamic brain regions: Differential sensitivity to corticosterone. Neuroendocrinology 52:626-631.
48. Paulson PE, Robinson TE. 1994. Relationship between circadian changes in spontaneous motor activity and dorsal versus ventral striatal dopamine neurotransmission assessed with on-line microdialysis. Behav Neurosci 108:624-635.
49. Paxinos G, Watson C. 1997. The rat brain in stereotaxic coordinates. San Diego: Academic Press.
50. Piazza PV, Rougé-Pont F, Deroche V, Maccari S, Simon H, Le Moal M. 1996. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci USA 93:8716-8720. (Pubitemid 26269626)
51. Reul JM, de Kloet ER. 1985. Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 117:2505-2511.
52. Reul JM, van den Bosch FR, de Kloet ER. 1987. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: Functional implications. J Endocrinol 115:459-467.
53. Reul JMHM, Gesing A, Droste S, Stec ISM, Weber A, Bachmann C, Bilang-Bleuel A, Holsboer F, Linthorst ACE. 2000. The brain mineralocorticoid receptor: Greedy for ligand, mysterious in function. Eur J Neurosci 405:235-249. (Pubitemid 30734183)
54. Saal D, Dong Y, Bonci A, Malenka RC. 2003. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37:577-582. (Pubitemid 36262980)
55. Sabeti J, Gerhardt GA, Zahniser NR. 2003. Chloral hydrate and ethanol, but not urethane, alter the clearance of exogenous dopamine recorded by chronoamperometry in striatum of unrestrained rats. Neurosci Lett 343:9-12. (Pubitemid 36577200)
56. Schultz W. 2007. Behavioral dopamine signals. Trends Neurosci 30:203-210.
57. Sica DA. 2005. Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis. Heart Fail Rev 10:23-29.
58. Singer SS. 1978. Enzymatic sulfation of steroids. II. The sulfation of corticosterone by the glucocorticoid sulfotransferases of rat liver cytosol. Biochim Biophys Acta 539:19-30.
59. Trapp T, Holsboer F. 1996. Heterodimerization between mineralo-corticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action. Trends Pharmacol Sci 17:145-149. (Pubitemid 26121158)
60. Trapp T, Rupprecht R, Castrén M, Reul JM, Holsboer F. 1994. Heterodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS. Neuron 13:1457-1462.
61. Veldhuis HD, Van Koppen C, Van Ittersum M, De Kloet ER. 1982. Specificity of the adrenal steroid receptor system in rat hippocampus. Endocrinology 110:2044-2051.
62. Zetterström T, Sharp T, Collin AK, Ungerstedt U. 1988. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications or the origin of extracellular DOPAC. Eur J Pharmacol 148:327-334.